PELOBIN Trademark

Trademark Overview


On Monday, August 8, 2005, a trademark application was filed for PELOBIN with the United States Patent and Trademark Office. The USPTO has given the PELOBIN trademark a serial number of 78687855. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 24, 2013. This trademark is owned by Takeda Pharmaceutical Company Limited. The PELOBIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculosketetal disorders
pelobin

General Information


Serial Number78687855
Word MarkPELOBIN
Filing DateMonday, August 8, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 24, 2013
Registration Number3157311
Registration DateTuesday, October 17, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDS, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculosketetal disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 24, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTakeda Pharmaceutical Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChuo-ku, Osaka
JP

Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChuo-ku, Osaka
JP

Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChuo-ku, Osaka
JP

Trademark Events


Event DateEvent Description
Friday, May 24, 2013CANCELLED SEC. 8 (6-YR)
Tuesday, October 17, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, August 1, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2006NOTICE OF PUBLICATION
Wednesday, June 14, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 9, 2006ASSIGNED TO LIE
Friday, June 2, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 2, 2006EXAMINER'S AMENDMENT ENTERED
Friday, June 2, 2006EXAMINERS AMENDMENT E-MAILED
Friday, June 2, 2006EXAMINERS AMENDMENT -WRITTEN
Friday, June 2, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, June 2, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 17, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, May 1, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 1, 2006PAPER RECEIVED
Monday, February 27, 2006NON-FINAL ACTION E-MAILED
Monday, February 27, 2006NON-FINAL ACTION WRITTEN
Monday, February 27, 2006ASSIGNED TO EXAMINER
Friday, August 12, 2005NEW APPLICATION ENTERED IN TRAM